Riskpilot← Back to searchSign inGet full accessVildvittra AB
ABActiveOrg 5568877707Grimmestorps EgendomMedical specialists activities · NACE 8622Est. 20120 employees
Revenue 2025
SEK 858K
+36% vs 2024
EBITDA margin
10.7%
+115% vs 2024
Equity ratio
36.2%
Financial strength
Net profit 2025
SEK -46K
-13% vs 2024
| Revenue | SEK 858K | +36% |
| EBITDA | SEK 91K | +115% |
| Net profit | SEK -46K | -13% |
| Total assets | SEK 5M | -9% |
| Equity | SEK 1,8M | -22% |
| Employees | 0 | — |
Legal name
Vildvittra AB
Org number
5568877707
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
15 mars 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall, direkt eller indirekt, bedriva privat läkarmottagning samt konsultverksamhet inom läkaryrket, konsultuppdrag inom industriell elektronik odch byggteknik samt därmed förenlig verksamhet.
Address
Grimmestorps Egendom
Email
jorgen.filipsson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 14 399 | 12 093 | 2 532 | 630 | 858 |
| Staff expenses | — | — | −1 476 | −282 | −313 |
| EBITDA | 1 340 | −90 | −704 | −629 | 91 |
| Depreciation & amort. | −0 | −0 | — | — | −19 |
| EBIT | 1 340 | −90 | −704 | −629 | 72 |
| Net financials | −67 | −55 | 3 065 | 588 | −119 |
| Profit before tax | 1 099 | −145 | 2 361 | −41 | −46 |
| Tax | −238 | −0 | — | — | — |
| Net profit | 861 | −145 | 2 361 | −41 | −46 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 920 | 6 553 | 5 777 | 5 554 | 5 035 |
| Equity | 2 505 | 2 054 | 2 465 | 2 334 | 1 821 |
| Long-term debt | 3 153 | 3 220 | 3 187 | 3 154 | 3 121 |
| Short-term debt | 1 262 | 1 279 | 125 | 67 | 93 |
| Total debt | 4 415 | 4 499 | 3 312 | 3 220 | 3 214 |
EBITDA margin
10.7%
This company
15.8%
Market median
-32% vs market
20212025
Equity ratio
36.2%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
20212025
Net profit margin
-5.4%
This company
8.1%
Market median
-167% vs market
20212025
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20212025
Debt / equity
1.76×
This company
0.62×
Market median
-184% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PC Audit | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vildvittra AB 
Doktor Anne ABBoard members of Vildvittra AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pia Christina Haller | Audit | 0 companies |
| Anne Christina Filipsson | Board of Directors | 0 companies |
| Ulf Filip Jörgen Filipsson | Deputy Board Member | 0 companies |